Indeed, the link between PAPP-A and BC was reported even prior to the discovery of PAPP-A function and its involvement in the IGF system; wherein independent of estrogen receptor (ER) status in stage I BC, PAPP-A was found to be a clinically significant predictor of early recurrence [23]. Here, IGF1 is linked to breast cancer.